Precigen (PGEN) Gross Margin (2013 - 2026)
Precigen (PGEN) posted quarterly Gross Margin of 88.99% for Q1 2026, up 7102.0% year-over-year from 1.24% in Q1 2025, and up 11.65% quarter-over-quarter from 79.71% in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Gross Margin (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Gross Margin for 14 consecutive years, with 88.99% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 7102.0% year-over-year to 88.99%; the TTM figure through Mar 2026 stood at 80.87% (up 5553.0% YoY), while the FY2025 annual figure was 50.2%, up 5891.0% from the prior year.
- Gross Margin climbed to 88.99% in Q1 2026 per PGEN's latest filing, from 79.71% in the prior quarter.
- Across five years, Gross Margin topped out at 108.64% in Q4 2022 and bottomed at 153600.0% in Q3 2023.
- Historically, Gross Margin has averaged 15871.17% across 5 years, with a median of 10.97% in 2023.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 15368922 bps — and 2025, when it jumped 10079013 bps.
- Precigen's Gross Margin stood at 108.64% in 2022, then slumped by 110 bps to 10.59% in 2023, then jumped by 745 bps to 68.32% in 2024, then gained by 17 bps to 79.71% in 2025, then rose by 12 bps to 88.99% in 2026.
- Business Quant data shows PGEN's Gross Margin at 88.99% in Q1 2026, 79.71% in Q4 2025, and 9.87% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 94.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.90% |
| Mar 31, 2026 | 88.99% |
| Dec 31, 2025 | 65.04% |
| Sep 30, 2025 | 64.58% |
| Jun 30, 2025 | -27.57% |
| Mar 31, 2025 | 17.97% |
| Dec 31, 2024 | 1.76% |
| Sep 30, 2024 | -5.88% |
| Jun 30, 2024 | -41.42% |
| Mar 31, 2024 | -0.94% |
| Dec 31, 2023 | -10.59% |
| Sep 30, 2023 | -11.46% |
| Jun 30, 2023 | 3.96% |
| Mar 31, 2023 | 17.50% |
| Dec 31, 2022 | 28.70% |
| Sep 30, 2022 | 90.57% |
| Jun 30, 2022 | 37.79% |
| Mar 31, 2022 | 69.27% |
| Dec 31, 2021 | 21.63% |
| Sep 30, 2021 | 70.90% |